HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) has been shown to cause G2 cell cycle arrest in human cells by inducing ATR-mediated inactivation of p34cdc2, but factors directly engaged in this process remain unknown. We used tandem affinity purification to isolate native Vpr complexes. We found that damaged DNA binding protein 1 (DDB1), viral protein R binding protein (VPRBP), and cullin 4A (CUL4A)--components of a CUL4A E3 ubiquitin ligase complex, DDB1-CUL4A(VPRBP)--were able to associate with Vpr. Depletion of VPRBP by small interfering RNA impaired Vpr-mediated induction of G2 arrest. Importantly, VPRBP knockdown alone did not affect normal cell cycle progression or activation of ATR checkpoints, suggesting that the involvement of VPRBP in G2 arrest was specific to Vpr. Moreover, leucine/isoleucine-rich domain Vpr mutants impaired in their ability to interact with VPRBP and DDB1 also produced strongly attenuated G2 arrest. In contrast, G2 arrest-defective C-terminal Vpr mutants were found to maintain their ability to associate with these proteins, suggesting that the interaction of Vpr with the DDB1-VPRBP complex is necessary but not sufficient to block cell cycle progression. Overall, these results point toward a model in which Vpr could act as a connector between the DDB1-CUL4A(VPRBP) E3 ubiquitin ligase complex and an unknown cellular factor whose proteolysis or modulation of activity through ubiquitination would activate ATR-mediated checkpoint signaling and induce G2 arrest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through DCAF1, Vpr interacts with damaged DNA binding protein 1 (DDB1) as part of the Cul4A E3 ubiquitin ligase complex where host proteins recruited by Vpr are ubiquitylated and degraded17–22.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · cited 1×
“Inactivation of cdc2/cyclin by hyperphosphorylation and cytoplasmic retention prevents entry into mitosis before the completion of DNA repair [10,12].”
BackgroundCell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966 · cited 1×
“Inactivation of cdc2/cyclin by hyperphosphorylation and cytoplasmic retention prevents entry into mitosis before the completion of DNA repair [10,12].”
BackgroundThe Tandem Affinity Purification (TAP) Method: A General Procedure of Protein Complex Purification
Puig, O., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., Wilm, M., & Séraphin, B. (2001) · Methods · doi:10.1006/meth.2001.1183 · Cited by 1,783 · cited 2×
“For the construction of mammalian expression plasmid psvCMV-TAP, N-terminal TAP tag was first PCR amplified from the pBS1479 plasmid [58] using primers 59-TCTAGACATATGGCAGGCCTTGCGCAAC-39 and 59-GGATCCTCACTACTCGAA-TCGTCATCATCAAGTGCC-39, the last one containing two stop codons between the XhoI and BamHI restriction site…”
MethodWood, R. D., Mitchell, M., Sgouros, J., & Lindahl, T. (2001) · Science · doi:10.1126/science.1056154 · Cited by 1,466 · cited 1×
“The other 120-kDa protein was identified as DDB1, initially considered part of a heterodimeric complex containing damaged DNA binding protein 2 (DDB2), involved in a cellular response to UV-induced DNA damages [24,25].”
BackgroundZufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014 · cited 1×
“Vectors were titered as described previously with some modifications [61].”
MethodHe, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904 · cited 3×
“the p34cdc2/cyclin B complex [3,4].”
BackgroundGroisman, R., Polanowska, J., Kuraoka, I., Sawada, J.-I., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K., & Nakatani, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00316-7 · Cited by 744 · cited 3×
“In contrast, DDB1-CUL4ACSA and DDB1-CUL4ADET1-COP1 promote proteolysis of Cockayne syndrome type B gene product (CSB) [26] and c-JUN [41].”
BackgroundInfluentialMolecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery
Angers, S., Li, T., Yi, X., MacCoss, M. J., Moon, R. T., & Zheng, N. (2006) · Nature · doi:10.1038/nature05175 · Cited by 674 · cited 1×
“]. In this complex, DDB1 serves as a scaffold protein presenting substrate to the E3 ubiquitin ligase. The protein is structurally complex and contains three seven-bladed β propellers (βPA, βPB, and βPC) [”
BackgroundJin, J., Arias, E. E., Chen, J., Harper, J. W., & Walter, J. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.010 · Cited by 632 · cited 6×
“Therefore, given the mutual association of Vpr (Figure 1A, 1C, and 1D therein and [21,22]) and CUL4A (Figure 3B therein and [20]) with VPRBP, these results suggest that Vpr interacts with the DDB1-CUL4A E3 ubiquitin ligase in a single complex and that this association might occur via the intermediary of VPRBP.”
BackgroundMethodInfluentialUV-Induced Ubiquitylation of XPC Protein Mediated by UV-DDB-Ubiquitin Ligase Complex
Sugasawa, K., Okuda, Y., Saijo, M., Nishi, R., Matsuda, N., Chu, G., Mori, T., Iwai, S., Tanaka, K., Tanaka, K., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.035 · Cited by 576 · cited 1×
“In human cells, DDB1-CUL4A promotes the ubiquitylation of histone 2A [38], histone 3, histone 4 [39], and the xeroderma pigmentosum group C protein (XPC) to regulate their activity [40].”
Background
Cited by
Items 101–187 of 187
Roles of Vpr and Vpx in modulating the virus-host cell relationship
Planelles, V., & Barker, E. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.002 · Cited by 26
“…with VprBP/DCAF1, Vpr is capable of binding to a larger complex that includes Cul4A, DDB1, Rbx1/Roc1 and a ubiquitin conjugating enzyme or E2 (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schrofelbauer, Hakata, and Landau, 2007; Tan, Ehrlich, and…”
BackgroundThe host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication
Ali, A., Farooqui, S. R., & Banerjea, A. C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007257 · Cited by 27
“Similarly, Vpr uses CULLIN4 for G2 cell cycle arrest for enhanced viral replication and virion production (14).”
BackgroundFabits, M., Magalhães, V. G., Chan, B., Girault, V., Elbasani, E., Rossetti, E., Saeland, E., Messerle, M., Pichlmair, A., Lisnić, V. J., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8060790 · Cited by 29
“Because DCAF1 is utilized by multiple viral proteins to modulate the host [22,44,45], we asked whether this complex or the direct UL35 interaction partner DCAF1 itself contributes to the antagonistic function of UL35.”
HIV-1 Vpr induces ciTRAN to prevent transcriptional repression of the provirus
Bhardwaj, V., Singh, A., Choudhary, A., Dalavi, R., Ralte, L., Chawngthu, R. L., Kumar, N. S., Vijay, N., & Chande, A. G. (2023) · Science Advances · doi:10.1126/sciadv.adh9170 · Cited by 29
Zhou, X., DeLucia, M., Hao, C., Hrecka, K., Monnie, C. M., Skowroński, J., & Ahn, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798801 · Cited by 31
“DCAF1c (1045-1396) DCAF1 (817-1396) DCAF1 (1-1396) Time A B”
Visualizing Vpr-Induced G2 Arrest and Apoptosis
Murakami, T., & Aida, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086840 · Cited by 25
Cui, M., Huang, Y., Zhao, Y. L., & Zheng, J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_11 · Cited by 24
HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis
Hossain, D., Barbosa, J. A. F., Cohen, É. A., & Tsang, W. Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001444 · Cited by 23
“At 48 h posttransfection, cells were fixed, permeabilized, and stained with propidium iodide as described (55).”
MethodSelf-citationVpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
Lubow, J., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12080809 · Cited by 30
Chronic HIV Transcription, Translation, and Persistent Inflammation
Kilroy, J. M., Leal, A. A., & Henderson, A. J. (2024) · Viruses · doi:10.3390/v16050751 · Cited by 25
“The ability of Vpr to alter cell function is, in part, due to its binding and co-opting of the host E3 ubiquitin ligase complex Cullin Ring Ligase 4/DDB1, Cul4 Associated Factor 1 complex, and the CRL4 DCAF E3 ubiquitin ligase complex [35,73].”
BackgroundSubversion of Cell Cycle Regulatory Mechanisms by HIV
Rice, A. P., & Kimata, J. T. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.010 · Cited by 21
“…ligase complex, and analyses of mutant Vpr proteins indicated that this association is required 738 Cell Host & Microbe 17, June 10, 2015 ª2015 Elsevier Inc. for cell cycle arrest (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schröfelbauer et al., 2007).”
BackgroundMaudet, C., Bertrand, M., Rouzic, E. L., Lahouassa, H., Ayinde, D., Nisole, S., Goujon, C., Cimarelli, A., Margottin-Goguet, F., & Transy, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220780 · Cited by 26
Navigating the Nexus: HIV and Breast Cancer—A Critical Review
Marıno, A., Pavone, G., Martorana, F., Fisicaro, V., Motta, L., Spampinato, S., Celesia, B. M., Cacopardo, B. S., Vigneri, P. G., & Nunnari, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063222 · Cited by 20
“…not only facilitate the initiation and progression of malignancies but also suggest potential targets for therapeutic intervention and highlight the importance of monitoring gene expression changes in HIV-infected patients as a part of their cancer risk assessment and management strategies.”
BackgroundLandsberg, C. D., Megger, D. A., Hotter, D., Rückborn, M. U., Eilbrecht, M., Rashidi‐Alavijeh, J., Howe, S., Heinrichs, S., Sauter, D., Sitek, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02978 · Cited by 23
Evidence for Vpr-dependent HIV-1 Replication in Human CD4+CEM.NKR T-Cells
Zhou, T., Dang, Y., Baker, J. J., Zhou, J., & Zheng, Y. (2012) · Retrovirology · doi:10.1186/1742-4690-9-93 · Cited by 20
“The Vpr Q65R mutant does not bind to DCAF1 and therefore does not induce G2 arrest [49]; although the R80A mutant binds to DCAF1, it does not induce G2 arrest [26,50].”
Nonaka, M., Hashimoto, Y., Takeshima, S., & Aida, Y. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-20 · Cited by 19
The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest
Sharifi, H. J., Furuya, A. K. M., & de Noronha, C. M. C. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835049e0 · Cited by 21
Gérard, F. C. A., Yang, R., Romani, B., Poisson, A. O., Belzile, J.-P., Rougeau, N., & Cohen, É. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089195 · Cited by 19
Self-citationChen, S., Yang, X., Cheng, W., Ma, Y., Shang, Y., Cao, L., Chen, S., Chen, Y. Z., Wang, M., & Guo, D. (2017) · Retrovirology · doi:10.1186/s12977-017-0338-5 · Cited by 18
Richard, J., Pham, T. N. Q., Ishizaka, Y., & Cohen, É. A. (2013) · Virology · doi:10.1016/j.virol.2013.04.037 · Cited by 19
Self-citationHIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest
Liang, Z., Liu, R., Lin, Y., Liang, C., Tan, J., & Qiao, W. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3654-8 · Cited by 17
Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP
Wang, B., Liu, Y., Yang, Y., Zhang, Y., Hao, J., Yang, H., Wang, X., Zhang, Z., Zhan, Q., & Wang, M. (2012) · Clinical Science · doi:10.1042/cs20120270 · Cited by 18
14-3-3s are potential biomarkers for HIV-related neurodegeneration
Morales, D. V., Skoulakis, E. M. C., & Acevedo, S. F. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0121-2 · Cited by 18
“G2 arrest provides a replication advantage for the virus because the proviral transcription level is known to be elevated during the G2 phase of the cell cycle (Belzile et al. 2007; Elder et al. 2001; Goh et al. 1998; Tyson et al. 2002).”
BackgroundMass Spectrometry-Based Proteomic Approaches for Discovery of HIV–Host Interactions
Luo, Y., & Muesing, M. A. (2014) · Future Virology · doi:10.2217/fvl.14.86 · Cited by 17
HIV-1 Vpr Functions in Primary CD4+ T Cells
Vanegas-Torres, C. A., & Schindler, M. (2024) · Viruses · doi:10.3390/v16030420 · Cited by 19
Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr
DePaula-Silva, A. B., Cassiday, P. A., Chumley, J., Bosque, A., Monteiro-Filho, C. M., Mahon, C. S., Cone, K. R., Krogan, N. J., Elde, N. C., & Planelles, V. (2015) · Virology · doi:10.1016/j.virol.2014.12.040 · Cited by 15
“Vpx triggers degradation of SAMHD1 by associating with DCAF1 and recruiting SAMHD1 to the CRUL4DDB1/DCAF1 E3 ligase.”
BackgroundPham, T. N. Q., Richard, J., Gérard, F. C. A., Power, C., & Cohen, É. A. (2011) · Journal of Virology · doi:10.1128/jvi.05835-11 · Cited by 15
Self-citationHow SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest
Blondot, M.-L., Dragin, L., Lahouassa, H., & Margottin-Goguet, F. (2014) · Retrovirology · doi:10.1186/preaccept-2057766064124418 · Cited by 19
Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2014) · Journal of Virology · doi:10.1128/jvi.00241-14 · Cited by 16
HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome
Li, G., Elder, R. T., Dubrovsky, L., Liang, D., Pushkarsky, T., Chiu, K., Fan, T., Sire, J., Bukrinsky, M., & Zhao, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011371 · Cited by 19
Barnitz, R. A., Chaigne-Delalande, B., Bolton, D. L., & Lenardo, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024924 · Cited by 16
Hakata, Y., Miyazawa, M., & Landau, N. R. (2014) · Virology Journal · doi:10.1186/1743-422x-11-108 · Cited by 13
“In previous reports, the association of Vpr with DCAF1 and DDB1 was examined by co-immunoprecipitation using several Vpr mutants and the results indicated that the binding to DCAF1 fully coincided with the association with DDB1 for all tested mutants [22-24,27].”
BackgroundInfluentialHIV1‐viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies
Soares, R., Rocha, G., Meliço-Silvestre, A. A., & Gonçalves, T. (2016) · Reviews in Medical Virology · doi:10.1002/rmv.1889 · Cited by 14
Perinuclear localization of the HIV-1 regulatory protein Vpr is important for induction of G2-arrest
Sörgel, S., Fraedrich, K., Votteler, J., Thomas, M., Stamminger, T., & Schubert, U. (2012) · Virology · doi:10.1016/j.virol.2012.06.027 · Cited by 16
Cell context-dependent involvement of ATR in early stages of retroviral replication
Yang, Y., Guen, V. J., Richard, J., Cohen, É. A., & Berthoux, L. (2009) · Virology · doi:10.1016/j.virol.2009.10.032 · Cited by 15
“ATR activation results in cell cycle arrest, and the HIV-1 protein Vpr has been proposed to prevent progression from the G2 phase of the cell cycle by activating a pathway that includes ATR (Andersen et al., 2005; Belzile et al., 2007; Dehart and Planelles, 2008; Zimmerman et al., 2006).”
BackgroundSelf-citationBarbosa, J. A. F., Sparapani, S., Boulais, J., Lodge, R., & Cohen, É. A. (2021) · Journal of Virology · doi:10.1128/jvi.00971-20 · Cited by 16
Self-citationBowen, N. E., Oo, A., & Kim, B. (2022) · Viruses · doi:10.3390/v14081622 · Cited by 14
Cif type III effector protein: A smart hijacker of the host cell cycle
Samba‐Louaka, A., Taieb, F. E., Nougayrède, J., & Oswald, É. (2009) · Future Microbiology · doi:10.2217/fmb.09.60 · Cited by 12
Burnett, J., & Rossi, J. J. (2009) · Gene Therapy · doi:10.1038/gt.2009.86 · Cited by 12
E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation
Oswald, J., Constantine, M., Adegbuyi, A., Omorogbe, E., Dellomo, A. J., & Ehrlich, E. S. (2023) · Viruses · doi:10.3390/v15091935 · Cited by 12
Binding to DCAF1 distinguishes TASOR and SAMHD1 degradation by HIV-2 Vpx
Martin, M. M., Matkovic, R., Larrous, P., Morel, M., Lasserre, A., Vauthier, V., & Margottin-Goguet, F. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009609 · Cited by 15
Jung, J., Byeon, I. L., DeLucia, M., Koharudin, L. M. I., Ahn, J., & Gronenborn, A. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534453 · Cited by 12
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx
Cassiday, P. A., DePaula-Silva, A. B., Chumley, J., Ward, J. P., Barker, E., & Planelles, V. (2014) · Virology · doi:10.1016/j.virol.2014.11.024 · Cited by 14
“In support of this hypothesis, analogous mutations in the third helix of both Vpr (Q65R) and Vpx (Q76R) have been shown to abrogate interaction with DCAF1 (Belzile et al., 2007; Dehart et al., 2007; Le Rouzic et al., 2007; Schröfelbauer et al., 2007; Srivastava et al., 2008).”
InfluentialRestriction of Retroviral Infection of Macrophages
Sharkey, M. E. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_4 · Cited by 12
HIV-1 Viral Protein R: From Structure to Function
Fritz, J. V., Briant, L., Mély, Y., Bouaziz, S., & de ROCQUIGNY, H. (2010) · Future Virology · doi:10.2217/fvl.10.47 · Cited by 14
Targeting Protein–Protein Interactions for HIV Therapeutics
Rice, A. P., & Sutton, R. E. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.369 · Cited by 11
CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
Dobransky, A., Root, M., Hafner, N., Marcum, M., & Sharifi, H. J. (2024) · Viruses · doi:10.3390/v16081313 · Cited by 13
“The mechanism by which Vpr induces cell cycle arrest came to light after a burst of publications identified the CRL4-DCAF1 ubiquitin ligase complex as an interaction partner for Vpr [49,66,78–82].”
BackgroundFunctional integrity of naturally occurring mutants of HIV-1 subtype C Vpr
Romani, B., Glashoff, R. H., & Engelbrecht, S. (2010) · Virus Research · doi:10.1016/j.virusres.2010.08.020 · Cited by 9
Giuliani, E., Vassena, L., Galardi, S., Michienzi, A., Desimio, M. G., & Doria, M. (2018) · Virology · doi:10.1016/j.virol.2018.07.031 · Cited by 9
Coggins, S. A., Holler, J. M., Kimata, J. T., Kim, D., Schinazi, R. F., & Kim, B. (2019) · Virology · doi:10.1016/j.virol.2019.08.010 · Cited by 7
“Many SIV strains from various primate species counteract the anti-viral activity of SAMHD1 by targeting the host protein for E3-ligase dependent proteasomal degradation (9,13,16,17,51).”
BackgroundMcCulley, A., & Ratner, L. (2012) · Virology · doi:10.1016/j.virol.2012.02.002 · Cited by 7
“Vpr, but not Vpx, induces cell cycle arrest and apoptosis (Belzile et al., 2007; Fletcher et al., 1996).”
BackgroundFourati, S., Malet, I., Guenzel, C. A., Soulié, C., Maidou-Peindara, P., Morand‐Joubert, L., Wirden, M., Sayon, S., Peytavin, G., Simon, A., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.11.008 · Cited by 8
Ubiquitin ligases as therapeutic targets in HIV-1 infection
Votteler, J., & Schubert, U. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.131 · Cited by 8
Saladino, N., & Salamango, D. J. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1410258 · Cited by 9
Coggins, S. A., Kim, D., Schinazi, R. F., Desrosier, R. C., & Kim, B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015273 · Cited by 4
HIV-1 Vpr increases HCV replication through VprBP in cell culture
Yan, Y., Huang, F., Yuan, T., Sun, B., & Yang, R. (2016) · Virus Research · doi:10.1016/j.virusres.2016.07.007 · Cited by 5
Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages
Murakami, T., Matsuura, R., Chutiwitoonchai, N., Takei, M., & Aida, Y. (2021) · Viruses · doi:10.3390/v13112308 · Cited by 4
“Vpr-induced G2 arrest requires the association of Vpr with the CUL4 ubiquitin ligase in association with DDB1 and DCAF1 [24,34–38].”
BackgroundInfluentialHIV-1 Vpr: Regulator of Viral Survival
Thieu, K. P., Morrow, M. P., Shedlock, D. J., Schoenly, K., Mallilankaraman, K. B., Choo, A. Y., Fagone, P., Weiner, D. B., & Muthumani, K. (2009) · Current HIV Research · doi:10.2174/157016209787581454 · Cited by 8
HIV-1 Vpr orchestrates ciTRAN upregulation through TGF-β induction
Choudhary, A., Mallick, K., Dalavi, R., & Chande, A. G. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013332 · Cited by 3
Matsunaga, A., Ando, N., Yamagata, Y., Shimura, M., Gatanaga, H., Oka, S., & Ishizaka, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296502 · Cited by 4
Role of karyopherin nuclear transport receptors in nuclear transport by nuclear trafficking peptide
Teratake, Y., Kimura, Y., & Ishizaka, Y. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112893 · Cited by 3
HIV-1 Vif and Vpr cooperatively modulate the cell cycle to maximize per-cell virion production
Bandini, M., Ghone, D., Evans, E. L., Suzuki, A., & Sherer, N. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2511502122 · Cited by 5
Yokomizo, T., & Takahashi, Y. (2022) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2022.1078234 · Cited by 3
“VPRBP is a component of the DDB1-CUL4AVPRBP E3 ubiquitin ligase complex and is involved in the induction of G2 arrest (Belzile et al., 2007).”
BackgroundGoujon, C., Darlix, J. L., & Cimarelli, A. (2009) · PubMed · doi:10.1684/vir.2009.0268 · Cited by 2
“En effet, une série d’études récentes a montré que Vpr, qui est proche de Vpx, interagit avec un complexe E3 de liaison à l’ubiquitine [53-59].”
HIV-1 Vpr Induces Degradation of Nucleolar Protein CCDC137 as a Consequence of Cell Cycle ArrestPreprint
Martins, L. J., DePaula-Silva, A. B., & Planelles, V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.16.435666 · Cited by 2
HIV-1 Vpr and G2 Cell Cycle Arrest
Nomaguchi, M., & Adachi, A. (2011) · Future Microbiology · doi:10.2217/fmb.11.17 · Cited by 1
Fourati, S. (2012) · HAL · Cited by 1
HIV-1 Vpr alters cellular transcription by targeting the PAF1 complexPreprint
Biguet, M., Marno, K. M., Oliveira, N. M. M., Gibbons, J. M., Pade, C., Jones, C. E., Branco, M. R., & McKnight, Á. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.18.629146 · Cited by 1
Funk, M. (2018) · theses.fr (ABES) · doi:10.70675/0303ae66zace8z4f41zbc60zf747fb33a4aa · Cited by 2
Identification of the Function of the Vpx Protein of Primate Lentiviruses: A Dissertation
Zhu, X. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/cgm8-q756
Quintana–Cabrera, R. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.115648
HIV-1 Vpr Degrades TET2 to Suppress IRF7 and Interferon Expression in Plasmacytoid Dendritic CellsPreprint
Wang, Q., Tsao, L.-C., Lv, L., Xu, Y., Cheng, L., Yu, H., Zhang, L., Xiong, Y., & Su, L. (2019) · SSRN Electronic Journal · doi:10.1101/823328
“Both VprQ65R and VprR80A mutants are defective for induction of G2/M arrest (Belzile et al., 2007).”
BackgroundInfluentialThe positive regulation of HIV-1 Vif mRNA splicing is required for efficient virus replication
Exline, C. M., Roller, R. J., Russo, A. F., Varga, S. M., Perlman, S. M., & Stoltzfus, C. M. (2009) · doi:10.17077/etd.0rsvk6qc
DCAF1 promotes gastric cancer progression by PI3K/AKT/mTOR pathwayPreprint
Jiawei, Z. U. O., Qiao, Y., Shen, Y., Su, X., & Liqing, Z. H. O. U. (2023) · Research Square · doi:10.21203/rs.3.rs-3604744/v1
Role of extracellular viral regulatory proteins in neuropathogenesis
Nonnemacher, M. R., Berman, R. E., Lawrence, J. M., Collins, M. E., Gurrola, T. E., Dampier, W., & Wigdahl, B. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00001-8
HIV-1 Vpr induces an NFAT-controlled transcriptional program in primary CD4+ T cells
Leyens, J., Vanegas-Torres, C. A., Darius, A., Seizer, R., Maurer, B., Sauter, D., Lotke, R., & Schindler, M. (2026) · mBio · doi:10.1128/mbio.03605-25 · Cited by 2
“Vpr-expressing VLPs were generated as described beforehand (23, 43, 44).”
Etude de la restriction des cellules myeloïdes à l'infection lentivirale
Berger, G. (2011) · theses.fr (ABES) · doi:10.70675/5e6df030z045bz41b7z9b06z96a73dc15f6c
Etude des mécanismes contrôlant la spécificité d'encapsidation des ARN dans le VIH-1
Didierlaurent, L. (2010) · theses.fr (ABES) · doi:10.70675/6af45cb6z95b9z414cz94fbzdcd9c17fde4a
Contre-mesures virales anti-CTIP2 dans le cadre d'une infection productive par le ViH-1
Forouzanfar, F. (2016) · theses.fr (ABES) · doi:10.70675/ceb9ed65z4c9dz45ecz94f2z1ea64b1f5e10
Antagonism of HUSH restriction by lentiviral Vpx and Vpr proteins
Chougui, G. (2018) · theses.fr (ABES) · doi:10.70675/a8f60021z4ac1z485az94c1za6a503874720
Mécanisme moléculaire de l'antagonisme du complexe HUSH par les protéines lentivirales Vpx et Vpr
Martin, M. M. (2021) · theses.fr (ABES) · doi:10.70675/eba7934fzf9faz4427zb0f8zfba715ee98c9
Conflit moléculaire entre les protéines Vpr et Vpx des virus HIV/SIV et les facteurs HUSH et SAMHD1
Larrous, P. (2023) · theses.fr (ABES) · doi:10.70675/fc16267dzad68z4beczb28bz9a828aba2035
Manipulation of the cell cycle by HIV-1
Bandini, M., & Sherer, N. M. (2026) · Biochemical Society Transactions · doi:10.1042/bst20250120
“DCAF1 binding is required for Vpr’s ability to induce cell cycle arrest [184,196–199], acting through a complex network of diverse effector proteins including but are not limited to MOV34, P34CDC2 (CDK1), CCDC137, SMN1, and components of the DNA repair machinery (Figure 2B) [36,37,183,188,200,201].”
Du, J., Li, Q., Wang, S.-H., Zhao, Y., & Zhao, K. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1971957
Metadata
- Authors
- Belzile, J.-P., Duisit, G., Rougeau, N., Mercier, J., Finzi, A., & Cohen, É. A.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Université de Montréal (CA)
- Corresponding author
- Cohen, Éric A
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-13
- Volume
- 3
- Issue
- 7
- Pages
- e85
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC1914068
- OpenAlex
- W2010577903
- Cited by
- 189
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 2 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 7 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 17 · 2013: 8 · 2012: 18
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- HIV-1 Vpr, G2 cell cycle arrest, VprBP, ubiquitination, viral protein-protein interaction
- MeSH terms
- Animals, Cells, Cultured, DNA-Binding Proteins, Goats, Humans, Rabbits, Transfection, Virus Replication, HIV-1, Gene Expression Regulation, Viral, G2 Phase, Two-Hybrid System Techniques, Gene Silencing, RNA Interference, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cullin Proteins, Mice, vpr Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.